News & Events

Observations, opinions, and opportunities presented by our experts


Precision’s Schafer and Shafrin Contribute to PharmaLive’s Special Feature on Value

In a special feature focused on drug pricing solutions and value, PharmaLive’s Christiane Truelove talks with Precision subject matter experts Jeremy Schafer and Jason Shafrin, who offer their perspectives on the complex landscape.


Jason Shafrin comments on ICER’s announcement to examine unsupported price increases

As the spotlight on manufacturers’ raising the prices of therapies already on the market shows no sign of dimming, one industry group recently unveiled its intentions to dig a little deeper into the topic. The Institute for Clinical and Economic Review (ICER) says it will create a series of so-called Unsupported Price Increase (UPI) reports that will examine whether price increases are justified.


Chou Outlines Key Challenges in US Biosimilars Marketplace in STAT News

In a special commentary appearing in STAT News, Jacki Chou, Senior Director, Policy & Economics,  and her co-author discuss overcoming 5 critical challenges in the US biosimilars marketplace, offering some strategic policy recommendations for the consideration of key healthcare stakeholders. […]

JCP Summarizes Baumgardner Study on CAR-T Treatment Cost-Effectiveness

In the latest edition of the Journal of Clinical Pathways (JCP), Zachary Bessette summarizes PHE Senior Research Economist Jim Baumgardner’s recent ASH presentation, focused on studying the cost-effectiveness of novel CAR-T treatments. In the study, Dr. Baumgardner’s team asserts that the introduction of CAR-T therapies represents a major break from the trend of declining incremental effectiveness and provides similar cost-effectiveness to other innovations.


Load More Posts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.